InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the full record of transactions filed by Desouza Errol B, 董事. Officer active across 4 companies, notably Royalty Pharma plc. In total, 11 disclosures have been published. History available since 25 June 2021. The latest transaction was disclosed on 11 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Desouza Errol B
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
28,700 股Common StockSEC:0001193125-26-274123:0
28,700 股0Common StockSEC:0000950170-25-085615:0
7,614 股0Class A Ordinary SharesSEC:0001802768-25-000049:0
9,293 股0Class A Ordinary SharesSEC:0001802768-24-000027:0
41,250 股0Common StockSEC:0000950170-24-034848:0
20,000 股0Common StockSEC:0000950170-23-067736:0
7,747 股0Class A Ordinary SharesSEC:0001209191-23-039672:0
6,328 股0Class A Ordinary SharesSEC:0000899243-22-024038:0
3,588 股0Common StockSEC:0001209191-21-059424:0
3,406 股0Common StockSEC:0001209191-21-044688:0
5,726 股0Class A Ordinary SharesSEC:0000950103-21-009693:0
11 条申报中的 11 条
About Desouza Errol B
DESOUZA ERROL B is Administrateur at Royalty Pharma plc, Alector, Inc., Catalyst Biosciences, INC., and Cyclerion Therapeutics, Inc. He has 11 filings in total, and the sampled recent filings run from 2021-06-29 to 2026-06-17, with the modal transaction nature shown as Attribution.
